Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis

MLA

Lorenzo Gerratana, et al. “Interplay between ESR1/PIK3CA Codon Variants, Oncogenic Pathway Alterations and Clinical Phenotype in Patients with Metastatic Breast Cancer (MBC): Comprehensive Circulating Tumor DNA (CtDNA) Analysis.” Breast Cancer Research, vol. 25, no. 1, Oct. 2023, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s13058-023-01718-0.

APA

Lorenzo Gerratana, Andrew A. Davis, Marko Velimirovic, Katherine Clifton, Whitney L. Hensing, Ami N. Shah, Charles S. Dai, Carolina Reduzzi, Paolo D’Amico, Firas Wehbe, Arielle Medford, Seth A. Wander, William J. Gradishar, Amir Behdad, Fabio Puglisi, Cynthia X. Ma, Aditya Bardia, & Massimo Cristofanilli. (2023). Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis. Breast Cancer Research, 25(1), 1–12. https://doi.org/10.1186/s13058-023-01718-0

Chicago

Lorenzo Gerratana, Andrew A. Davis, Marko Velimirovic, Katherine Clifton, Whitney L. Hensing, Ami N. Shah, Charles S. Dai, et al. 2023. “Interplay between ESR1/PIK3CA Codon Variants, Oncogenic Pathway Alterations and Clinical Phenotype in Patients with Metastatic Breast Cancer (MBC): Comprehensive Circulating Tumor DNA (CtDNA) Analysis.” Breast Cancer Research 25 (1): 1–12. doi:10.1186/s13058-023-01718-0.